Page last updated: 2024-10-27

gabexate and Ascites

gabexate has been researched along with Ascites in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Ascites: Accumulation or retention of free fluid within the peritoneal cavity.

Research Excerpts

ExcerptRelevanceReference
"The effects of protease inhibitors(PI), t-AMCHA, gabexate, aprotinin and heparin on the growth of mouse MM2 ascites tumor (MAT) and on several components of fibrinolysis were studied."3.67[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis]. ( Shibata, J, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, H1
Song, Q1
Lv, F1
Wang, S1
Wang, Y1
Li, X1
Luo, Y1
Mei, X1
Tang, J1
Shibata, J1

Other Studies

2 other studies available for gabexate and Ascites

ArticleYear
Protection Provided by a Gabexate Mesylate Thermo-Sensitive
    Gut and liver, 2017, Jan-15, Volume: 11, Issue:1

    Topics: Abdominal Injuries; Amylases; Animals; Apoptosis; Ascites; C-Reactive Protein; Edema; Gabexate; Gels

2017
[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis].
    Nihon Sanka Fujinka Gakkai zasshi, 1986, Volume: 38, Issue:5

    Topics: Animals; Aprotinin; Ascites; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Gab

1986